Prorelix Lifesciences Private Limited, a active private limited company, was established on 17 February 2016 in Pune, Maharashtra, India. Engaging in corporate training & development within the hospital and medical care sector, it holds CIN: U74999PN2016PTC158474. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹10.00 K .
It upholds a compliant status. Its leadership includes Niranjan Narendra Andhalkar (Director), Avinash Sakharam Auti (Director). Past directors included Niranjan Narendra Andhalkar. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 202-B, 2Nd Floor, Near State Bank Colony Survey No. 53, Park Plaza, Karve Nagar, Pune, Maharashtra, 411052.
U74999PN2016PTC158474
158474
17 February 2016
₹0.10 M
₹10.00 K
Roc Pune
Unlisted
Active
Explore comprehensive insights into Prorelix Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Niranjan Narendra Andhalkar | Director | 17 Feb 2016 | Current |
| Avinash Sakharam Auti | Director | 17 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Apr 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Prorelix Lifesciences Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 67% increase. The company also saw a substantial improvement in profitability, with a 62.65% increase in profit. The company's net worth Soared by an impressive increase of 95.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Prorelix Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Prorelix Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Prorelix Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prorelix Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Prorelix Lifesciences Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was recorded as a recent event.
The activity Prorelix Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Pune. was completed.
The activity Niranjan Narendra Andhalkar was appointed as a Director was appointed as a Director on 17 Feb 2016 & has been associated with this company since 9 years 10 months . was completed.
The activity Avinash Sakharam Auti was appointed as a Director was appointed as a Director on 17 Feb 2016 & has been associated with this company since 9 years 10 months . was completed.
The activity Prorelix Lifesciences Private Limited was registered on 17 Feb 2016 with Roc Pune & aged 9 years 10 months as per MCA records. was completed.
The CIN of Prorelix Lifesciences Private Limited is U74999PN2016PTC158474.
Prorelix Lifesciences Private Limited is headquartered at 202-B, 2Nd Floor, Near State Bank Colony Survey No. 53, Park Plaza, Karve Nagar, Pune, Maharashtra, 411052.
Prorelix Lifesciences Private Limited was incorporated on 17 February 2016.
The current directors of Prorelix Lifesciences Private Limited are
The primary industry of Prorelix Lifesciences Private Limited is Hospital And Medical Care.
Prorelix Lifesciences Private Limited is unlisted.
The authorized capital of Prorelix Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹10.00 K .
The compliance status of Prorelix Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX